DENOVO BIOPHARMA

denovo-biopharma-logo

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy. By identifying biomarkers correlated to patients' responsiveness to drug candidates retros... pectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in a targeted patient population to achieve significant efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in many therapeutic areas, such as oncology, metabolic, cardiology, immunology and neurology.

#SimilarOrganizations #People #Financial #Website #More

DENOVO BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2011-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.denovobiopharma.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
171.77 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Apache Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail


Similar Organizations

adgero-biopharmaceuticals-logo

Adgero Biopharmaceuticals

Adgero Biopharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on building a robust pipeline

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

nodexus-logo

Nodexus

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Employees Featured

wen-luo_image

Wen Luo
Wen Luo Chief Executive Officer, Chief Scientific Officer @ Denovo Biopharma
Chief Executive Officer, Chief Scientific Officer

michael-f-haller_image

Michael F. Haller
Michael F. Haller Chief Financial Officer @ Denovo Biopharma
Chief Financial Officer
2017-12-01

xiangming-fang_image

Xiangming Fang
Xiangming Fang Chief Operating Officer @ Denovo Biopharma
Chief Operating Officer
2012-02-01

ilia-ichetovkin_image

Ilia Ichetovkin
Ilia Ichetovkin Vice President, Companion Diagnostics @ Denovo Biopharma
Vice President, Companion Diagnostics
2021-01-01

Founder


xiangming-fang_image

Xiangming Fang

Investors List

cicc-qide_image

CICC Qide

CICC Qide investment in Series D - Denovo Biopharma

zhejiang-silicon-paradise-asset-management-group_image

Zhejiang Silicon Paradise Asset Management Group

Zhejiang Silicon Paradise Asset Management Group investment in Series D - Denovo Biopharma

china-resources-pharmaceutical-group_image

China Resources Pharmaceutical Group

China Resources Pharmaceutical Group investment in Series D - Denovo Biopharma

hosencare-brothers_image

HosenCare Brothers

HosenCare Brothers investment in Series D - Denovo Biopharma

zheshang-industrial-integration-asset-management_image

Zheshang Industrial Integration Asset Management

Zheshang Industrial Integration Asset Management investment in Series D - Denovo Biopharma

fang-fund-partners_image

Fang Fund Partners

Fang Fund Partners investment in Series D - Denovo Biopharma

yingke-capital_image

Yingke Capital

Yingke Capital investment in Series D - Denovo Biopharma

sangel-capital_image

Sangel Capital

Sangel Capital investment in Series D - Denovo Biopharma

cicc_image

CICC

CICC investment in Series C - Denovo Biopharma

share-capital_image

Share Capital

Share Capital investment in Series B - Denovo Biopharma

Official Site Inspections

http://www.denovobiopharma.com Semrush global rank: 1.89 M Semrush visits lastest month: 11.64 K

  • Host name: 43.153.101.214
  • IP address: 43.153.101.214
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "Denovo Biopharma" on Search Engine